ArticleTargeted oncology2024

Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2

Ondřej Fiala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.